DALLAS, Texas, Nov. 16 [Category: Health Care] -- The American Heart Association issued the following news release: Research Highlights: A new, multicenter study demonstrated that ablation treatment may be a better first option than medication for many heart attack survivors who develop abnormal electrical short circuits in their heart, which are episodes of dangerous rapid heart rhythms that can lead to fainting, heart failure or cardiac arrest. Currently, there are two main types of treatme  more

ANNAPOLIS, Maryland, Nov. 16 -- Gov. Wes Moore, D-Maryland, issued the following news release on Nov. 15, 2024: Governor Wes Moore today applauded a new contract with Carnival Cruise Line that keeps the world's largest cruise provider serving the Helen Delich Bentley Port of Baltimore for another five years. The agreement takes effect on January 1, 2025 and includes a five-year renewal option. "The international cruise industry recognizes Baltimore as one of the top cruise markets in our nati  more

CHICAGO, Illinois, Nov. 16 (TNSres) -- Northwestern University's Feinberg School of Medicine issued the following news release: * * * Outcomes of the largest, longest follow-up study of bariatric surgery in teens * * * Ten years after undergoing bariatric surgery as teens, over half of study participants demonstrated not only sustained weight loss, but also resolution of obesity-related conditions, such as type 2 diabetes, high blood pressure and high cholesterol, according to the report pub  more

DALLAS, Texas, Nov. 16 [Category: Health Care] -- The American Heart Association issued the following news release: Research Highlights: A study of almost 13,000 adults with Type 2 diabetes and high systolic blood pressure assessed if a more intensive treatment approach with a lower blood pressure goal would decrease the risk of major cardiovascular events, including non-fatal heart attacks, strokes and hospitalized heart failure, or death due to cardiovascular disease. In the Blood Pressure  more

DALLAS, Texas, Nov. 16 [Category: Health Care] -- The American Heart Association issued the following news release: Research Highlights: In an international trial of 713 adults in nine countries including the U.S. called SUMMIT, participants with heart failure with preserved ejection fraction (HFpEF) and obesity taking tirzepatide for an average of 2 years had reduced combined risk of worsening heart failure events and cardiovascular death, and improved health status and functional capacity co  more